Skip to main content
. 2017 Jul 14;8:328. doi: 10.3389/fneur.2017.00328

Figure 1.

Figure 1

Assessment of lipid peroxidation markers. (A) Hydroxynonenal, (B) malondialdehyde in plasma of Alzheimer’s disease and control. Data represents the mean ± SD. *P < 0.001, significantly different from control group.